Sanofi (SAN) News Today €101.46 -2.26 (-2.18%) As of 03/26/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSustainabilityBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Sanofi: Chlamydia vaccine candidate granted fast track designation by the US FDAMarch 26 at 7:45 AM | finanznachrichten.deSanofi Chlamydia vaccine candidate granted fast track designation by the US FDAMarch 26 at 2:45 AM | finanznachrichten.deSanofi: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisMarch 25 at 9:44 PM | finanznachrichten.deSanofi Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisMarch 25 at 3:23 AM | finanznachrichten.deSanofi Availability of the Q1 2025 Aide mémoireMarch 24 at 12:20 PM | finanznachrichten.deSanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibodyMarch 21, 2025 | msn.comBanks Launch €7.45 Billion Debt Sale for Sanofi Unit BuyoutMarch 21, 2025 | bloomberg.comPress Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineMarch 20, 2025 | markets.businessinsider.comSanofi strikes autoimmune drug deal for up to $1.9BMarch 20, 2025 | msn.comSanofi Agrees US Autoimmune Drug Deal for Up to $1.9 BillionMarch 20, 2025 | msn.comJaguars LB Chad Muma opens up on playing in the NFL with Type 1 DiabetesMarch 20, 2025 | msn.comDividend Rs 55 by pharma company; record date in AprilMarch 18, 2025 | msn.comBanks Aim to Sell €8.65 Billion Sanofi Buyout Debt Next WeekMarch 18, 2025 | bloomberg.comSanofi: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AADMarch 15, 2025 | finanznachrichten.deSanofi starts annual production of vaccines for 2025-26 flu seasonMarch 14, 2025 | markets.businessinsider.comMaine announces settlement to reduce insulin costsMarch 11, 2025 | msn.comAttorney General Aaron M. Frey Announces Settlement Agreement Will Bring $35 Insulin to MainersMarch 11, 2025 | msn.comSouth African Competition Commission probes Novo Nordisk and Sanofi over insulin pen marketMarch 10, 2025 | msn.comSanofi price target raised to EUR 120 from EUR 115 at BerenbergMarch 5, 2025 | markets.businessinsider.comBerenberg Bank Reaffirms Their Buy Rating on Sanofi (SNY)March 5, 2025 | markets.businessinsider.comEgg-based flu vaccine production secure despite avian influenzaMarch 4, 2025 | msn.comSouth African watchdog probes Novo Nordisk and Sanofi over insulinMarch 4, 2025 | msn.comHealth Rounds: Experimental drug delays heart valve disease progression, and potentially surgeryMarch 1, 2025 | reuters.comGlobal drug giant boosts Boulder biotech's funding round to $150 millionMarch 1, 2025 | bizjournals.comIs Sanofi (SNY) The Best Immunology Stock To Buy Now?March 1, 2025 | msn.comSanofi India share price rises up to 6% post Q4 results, Dividend announcementsFebruary 28, 2025 | msn.comNovavax sees royalties, reduced expenses on COVID vaccines from Sanofi partnershipFebruary 27, 2025 | msn.comSanofi, Schaeffler share price in focus as will consider dividend issue todayFebruary 26, 2025 | msn.comEnveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150MFebruary 26, 2025 | finance.yahoo.comSanofi’s Sarclisa combo approved in Japan for newly diagnosed MMFebruary 26, 2025 | finance.yahoo.comSanofi: Sarclisa approved in Japan for patients with newly diagnosed multiple myelomaFebruary 25, 2025 | finanznachrichten.deSanofi and Teva report new outcomes from Phase IIb trial of duvakitugFebruary 24, 2025 | finance.yahoo.comNotable healthcare headlines for the week: UnitedHealth, Moderna, Sanofi in focusFebruary 23, 2025 | msn.comTeva, Sanofi present new results from RELIEVE UCCD Phase 2b studyFebruary 23, 2025 | markets.businessinsider.comSanofi treatment of autoimmune hemolytic anemia granted orphan statusFebruary 20, 2025 | markets.businessinsider.comSanofi moves closer to selling controlling stake in $17bn-valued OpellaFebruary 19, 2025 | finance.yahoo.comRegeneron, Sanofi Get Speedy FDA Review of Dupixent in Bullous PemphigoidFebruary 18, 2025 | marketwatch.comFDA to review Sanofi and Regeneron’s Dupixent sBLA for bullous pemphigoidFebruary 18, 2025 | msn.comBanks on the Hook for Sanofi Buyout Face Agonizing Wait to SellFebruary 14, 2025 | finance.yahoo.comJ&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ resultsFebruary 13, 2025 | msn.comSanofi: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyFebruary 13, 2025 | finanznachrichten.deSanofi: Review Determined Vaccine Candidate for Extraintestinal Pathogenic E. Coli Not Sufficiently EffectiveFebruary 13, 2025 | marketwatch.comSanofi Ends Trial for E. Coli Shot and Takes a $250 Million HitFebruary 13, 2025 | bloomberg.comSanofi (SNY): Among the Best International Dividend Stocks to Buy NowFebruary 12, 2025 | msn.comSanofi is transferring its global expertise in insulin production to Saudi Arabia, aligning with Vision 2030 programFebruary 11, 2025 | msn.comSanofi: Execution of a share buyback agreement for up to €2 billionFebruary 7, 2025 | finanznachrichten.deSanofi To Repurchase EUR 2 Bln Worth Of SharesFebruary 7, 2025 | markets.businessinsider.comSanofi’s Sarclisa combo approved in China for multiple myelomaFebruary 3, 2025 | finance.yahoo.comL'ORÉAL: Agreement Between L'Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L'OréalFebruary 3, 2025 | finanznachrichten.deAgreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’OréalFebruary 3, 2025 | finance.yahoo.com Remove Ads Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address SAN Media Mentions By Week SAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAN News Sentiment▼0.140.78▲Average Medical News Sentiment SAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAN Articles This Week▼75▲SAN Articles Average Week Remove Ads Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Deutsche Bank Aktiengesellschaft News Today Bayer Aktiengesellschaft News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Genfit News Today Sartorius Stedim Biotech News Today Merck KGaA News Today Siemens Healthineers News Today Fresenius Medical Care News Today Carl Zeiss Meditec News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:SAN) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SAN Stock Free SAN Stock Alerts